Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Quantification of PSA mRNA levels in peripheral blood of patients with localized prostate adenocarcinoma before, during, and after radical prostatectomy by quantitative real-time PCR (qRT-PCR)
International Urology and Nephrology, 07/03/08
Kalfazade N et al. - In a study to evaluate the clinical value of detected prostate-specific antigen (PSA) mRNA expression levels in circulating cells in pts with prostate cancer by qRT-PCR and determine the effect of surgical manipulation on hematogenous dissemination, it seems that highly detectable PSA mRNA expression levels in preoperative samples seem to be a significant predictable factor for prostate cancer recurrence
Methods- Blood samples before, during, and after (24 h) surgery were obtained from 34 pts with prostate cancer who underwent radical prostatectomy for detecting PSA mRNA expression levels
- PSA mRNA expression levels, PSA levels, and Gleason scores were then compared
- PSA mRNA expression levels were detected in 14 of 34 pts, and biochemical recurrence of blood PSA was observed in 6 of 34 pts
- Differences of PSA mRNA expression levels in pre-, per-, and postoperative periods were statistically significant and differences of PSA mRNA expression levels in pre- and peroperative samples, pre- and postoperative samples, and per- and postoperative samples were also statistically meaningful
- There was significant relationship between the detectable PSA mRNA expression levels in preoperative samples and biochemical recurrence of blood PSA levels
- Surgical manipulation had no effect on biochemical recurrence of blood PSA
- There was significant correlation between high Gleason score and the detectable PSA mRNA expression levels
Related Articles
Double-Pigtail Stenting of the Ureters: Technique for Securing the Ureteral Orifices During Robot-Assisted Radical Prostatectomy for Large Median Lobes
Journal of Endourology, 11/30/09
Relevance Score: 67%
Detection of Subclinical CO2 Embolism by Transesophageal Echocardiography During Laparoscopic Radical Prostatectomy
Urology, 11/23/09
Relevance Score: 67%
Reducing blood loss in open radical retropubic prostatectomy with prophylactic periprostatic sutures
BJU International, 11/06/09
Relevance Score: 67%
Vessel-sealing devices safe for nerve-sparing radical prostatectomy
Urology Times, 11/06/09
Relevance Score: 67%
Laparoscopic radical prostatectomy: 10 years experience
International Braz J Urol, 11/03/09
Relevance Score: 67%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Thrombopoietin in normal and neoplastic stem cell development
Best Practice & Research: Clinical Haematology , 12/07/09
Mechanisms of mutations in myeloproliferative neoplasms
Best Practice & Research: Clinical Haematology , 12/07/09
Ursodeoxycholic acid switches oxaliplatin-induced necrosis to apoptosis by inhibiting reactive oxygen species production and activating p53-caspase 8 pathway in HepG2 hepatocellular carcinoma
International Journal of Cancer, 12/07/09
Today in Renal/Urologic...keeping you current
Receive free subspecialty "5-minute updates" via email
Total Cystectomy Versus Bladder Preservation Therapy for Locally Invasive Bladder Cancer: Effect of Combined Therapy Using Balloon-Occluded Arterial Infusion of Anticancer Agent and Hemodialysis With Concurrent Radiation
American Journal of Clinical Oncology, 12/07/09
Udp-glucose dehydrogenase as a novel field-specific candidate biomarker of prostate cancer
International Journal of Cancer, 12/07/09
Update on novel agents in renal cell carcinoma
Expert Review of Anticancer Therapy, 12/07/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


